Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only? - Publication - Bridge of Knowledge

Your account

login

Search

Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?

Abstract

Citations

  • 1 3

    CrossRef

  • 0

    Web of Science

  • 1 5

    Scopus

Authors (13)

  • Photo of Paulina Nazaruk

    Paulina Nazaruk

  • Photo of Marta Monticolo

    Marta Monticolo

  • Photo of Anna Jędrzejczak

    Anna Jędrzejczak

  • Photo of Natalia Krata

    Natalia Krata

  • Photo of Barbara Moszczuk

    Barbara Moszczuk

  • Photo of Joanna Sańko-Resmer

    Joanna Sańko-Resmer

  • Photo of Tomasz Pilecki

    Tomasz Pilecki

  • Photo of Arkadiusz Urbanowicz

    Arkadiusz Urbanowicz

  • Photo of Michał Florczak

    Michał Florczak

  • Photo of Leszek Pączek

    Leszek Pączek

  • Photo of Bartosz Foroncewicz

    Bartosz Foroncewicz

  • Photo of Krzysztof Mucha

    Krzysztof Mucha

  • Photo of Leszek Paczek

    Leszek Paczek

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
Vaccines no. 9, edition 12,
ISSN: 2076-393X
ISSN:
2076-393X
Publication year:
2021
DOI:
Digital Object Identifier (open in new tab) 10.3390/vaccines9121454
Verified by:
No verification

seen 0 times

Meta Tags